The business model of the pharmaceutical industry is changing fast: The era of blockbuster medications with big margins is over. Instead, patient-centric medication is the way forward. While the industry is still grappling with these facts competition from another side is entering the field: tech companies are currently investing heavily to reap large profits from e-health concepts. In the article the authors discuss how pharma companies can react in order to survive in this new environment.